| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ADDR.2016.07.001 |
| P8608 | Fatcat ID | release_geb3q33exbgupioqfqkvoy5sa4 |
| P698 | PubMed publication ID | 27422808 |
| P50 | author | Stefaan C De Smedt | Q39811098 |
| Wim Ceelen | Q43121460 | ||
| Katrien Remaut | Q48358345 | ||
| P2093 | author name string | George R Dakwar | |
| Wouter Willaert | |||
| Molood Shariati | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanomedicine | Q261659 |
| peritoneal carcinomatosis | Q2071182 | ||
| P304 | page(s) | 13-24 | |
| P577 | publication date | 2016-07-12 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis - Mission possible? | |
| P478 | volume | 108 |
| Q33754754 | 188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept |
| Q92140598 | Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review |
| Q92617865 | Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC- |
| Q90274720 | Biodistribution of Filamentous Plant Virus Nanoparticles: Pepino Mosaic Virus versus Potato Virus X |
| Q52866005 | Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. |
| Q48353664 | Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid |
| Q64933860 | Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study. |
| Q92618060 | Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis - a phase I first-in-human study |
| Q52626109 | Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy. |
| Q47165034 | Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis. |
| Q92617961 | Optimal drug delivery for intraperitoneal paclitaxel (PTX) in murine model |
| Q88718086 | Peritoneal Carcinomatosis Targeting with Tumor Homing Peptides |
| Q90356540 | Pharmacologic Properties of the Carrier Solutions for Hyperthermic Intraperitoneal Chemotherapy: Comparative Analyses Between Water and Lipid Carrier Solutions in the Rat Model |
| Q90754497 | Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer |
| Q92596522 | Strategies for Hyaluronic Acid-Based Hydrogel Design in Drug Delivery |
| Q38731251 | Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles. |
| Q38679465 | Tumour tissue transport after intraperitoneal anticancer drug delivery |
Search more.